Abstract
Snake venoms are rich in a large variety of proteins and peptides that can interfere with the hemostatic system. This review focuses on bothrojaracin, which is snaclec molecule, either bind to thrombin, inhibiting its biological activities, such as clotting of fibrinogen, platelet activation or to prothrombin, impairing thrombin formation. Bothrojaracin interacts with both molecules, forming a stable 1:1 complex. The calculated Kd for bothrojaracin was 0.6 nM and 100 nM for thrombin and prothrombin, respectively. Bothrojaracin binds to thrombin exosite I displacing ligands such as fibrin, hirudin, thrombomodulin and factor V and do not block the catalytic site. This protein has helped in our understanding of some molecular aspects of the thrombin and prothrombin structure–function relationship. The knowledge about the mechanism of action and details of structural aspects will certainly result in new medical and pharmacological applications. Furthermore, bothrojaracin offer attractive template for the development of rationally designed therapeutic agents.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Arocas, V., Zingali, R.B., Guillin, M.C., Bon, C., Jandrot-Perus, M., 1996. Bothrojaracin: a potent two-site-directed thrombin inhibitor. Biochemistry 35, 9083–9089.
Arocas, V., Castro, H.C., Zingali, R.B., Guillin, M.C., Jandrot-Perrus, M., Bon, C., Wisner, A., 1997. Molecular cloning and expression of bothrojaracin, a potent thrombin inhibitor from snake venom. Eur. J. Biochem. 248, 550–557.
Arocas, V., Lemaire, C., Bouton, M.C., Beazeaud, A., Bon, C., Guillin, M.C., Jandrot-Perrus, M., 1998. Inhibition of thrombin-catalysed factor V activation by bothrojaracin. Thromb. Haemost. 79, 1157–1161.
Assafim, M., Ferreira, M.S., Frattani, F.S., 2006. Counteracting effect of glycyrrhizin on the hemostatic abnormalities induced by Bothrops jararaca snake venom. Br. J. Pharmacol. 148, 807–813.
Atoda, H., Morita, T., 1989. A novel blood coagulation factor IX/factor X518 binding protein with anticoagulant activity from the venom of Trimeresurus flavoviridis (Habu snake): isolation and characterization. J. Biochem. 106, 808–813.
Atoda, H., Hyuga, M., Morita, T., 1991. The primary structure of coagulation factor IX/factor X-binding protein isolated from the venom of Trimeresurus flavoviridis. Homology with asialoglycoprotein receptors, proteoglycan core protein, tetranectin, and lymphocyte Fc epsilon receptor for immunoglobulin. J. Biol. Chem. 266, 14903–14911.
Atoda, H., Ishikawa, M., Yoshihara, E., Sekiya, F., Morita, T., 1995. Blood coagulation factor IX-binding protein from the venom of Trimeresurus flavoviridis: purification and characterization. J. Biochem. 118, 965–973.
Atoda, H., Ishikawa, M., Mizuno, H., Morita, T., 1998. Coagulation factor X binding protein from Deinagkistrodon acutus venom is a Gla domain-binding protein. Biochemistry 37, 17361–17370.
Atoda, H., Kaneko, H., Mizuno, H., Morita, T., 2002. Calcium-binding analysis and molecular modeling reveal Echis coagulation factor IX/factor X binding protein has the Ca-binding properties and Ca ion-independent folding of other C-type lectin-like proteins. FEBS Lett. 531, 229–234.
Bode, W., 2006. The structure of thrombin: a janus-headed proteinase. Sem. Throm. Hem. 32, 16–31.
Boffa, G.A., Boffa, M.C., Winchenne, J.J., 1976. A phospholipase A2 with anticoagulant activity. Isolation from Vipera berus venom and properties. Biochem. Biophys. Acta 429, 839–852.
Braud, S., Bon, C., Wisner, A., 2000. Snake venom proteins acting on hemostasis. Biochimie 82, 851–859.
Bukys, M.A., Orban, T., Kim, P.Y. Beck, D.O., Nesheim, M.E., Kalafatis, M., 2006. The structural integrity of anion binding exosite of thrombin is required and sufficient for timely cleavage and activation of factor V and factor VIII. J. Biol. Chem. 281, 18569–18580.
Castro, H.C., Dutra, D.L.S., Oliveira-Carvalho, A.L., Zingali, R.B., 1998. Bothroalternin, a thrombin inhibitor from the venom of Bothrops alternatus. Toxicon 36, 1903–1912.
Castro, H.C., Rodrigues, C.R., 2006. Current status of snake venom thrombin-like enzymes. Toxin Rev. 25, 291–318.
Castro, H.C., Zingali, R.B., Albuquerque, M.G., Pujol-luz, M., Rodrigues, C.R., 2004. Snake venom thrombin-like enzymes: from reptilase to now. Cell. Mol. Life Sci. 61, 843–856.
Chen, Y.L., Tsai, I.H., 1996. Functional and sequence characterization of coagulation factor IX/factor X-binding protein from the venom of Echis carinatus leucogaster. Biochemistry 35, 5264–5271.
Chippaux, J., Williams, V., White, J., 1991. Snake venom variability: methods of study results and interpretation. Toxicon 29, 1279–1303.
Clemetson, K.J., Morita, T., Kini, R.M., 2009. Scientific and standardization committee communications: classification and nomenclature of snake venom C-type lectins and related proteins. J. Thromb. Haemost. 7, 360.
Cox, A.C., 1993. Coagulation factor X inhibitor from hundred-pace snake (Deinagkistrodon acutus) venom. Toxicon 31, 1445–1457.
Davie, E.W., Fujikawa, K., Kisiel, W., 1991. The coagulation cascade: initiation, maintenance, and regulation. Biochemistry 30, 10363–10370.
Electricwala, A., von Sicard, N.A.E., Sawyer, R.T., Atkinson, T., 1993. Biochemical characterisation of a pancreatic elastase inhibitor from the leech Hirudinaria manillensis. J. Enzyme Inhib. 6, 293–302.
Esmon, C.T., Lollar, P., 1996. Involvement of thrombin anion-binding exosites 1 and 2 in the activation of factor V and factor VIII. J. Biol. Chem. 271, 13882–13887.
Fareed, J., Lewis, B.E., Callas, D.D., Hoppensteadt, D.A., Walenga, J.M., Bick, R.L., 1999. Antithrombin agents: the new class of anticoagulant and antithrombotic drugs. Clin. Appl. Thromb. Hemost. 5, S45–S55.
Fox, J.W., Serrano, S.M.T., 2009. Timeline of key events in snake venom metalloproteinase research. J. Proteomics 72, 200–209.
Francischetti, I.M., Gombarovits, M.E., Valenzuela, J.G., Carlini, C.R., Guimarães, J.A., 2000. Intraspecific variation in the venoms of the South American rattlesnake (Crotalus durissus terrificus). Comp. Biochem. Physiol. C. 127, 23–36.
Friedrich, T., Kroger, B., Bialojan, S., Lemaire, H.G., Hoffken, H.W., Reuschenbach, P., Otte, M., Dodt, J., 1993. A kazal-type inhibitor with thrombin specificity from Rhodnius prolixus. J. Biol. Chem. 268, 16216–16222.
Funk, C., Gmur, J., Herold, R., Straub, P.W., 1971. Reptilase-R: a new reagent in blood coagulation, Br. J. Haematol. 21, 43–52.
Glenn, J.L., Straight, R., 1978. Mojave rattle snake Crotalus scutulatus scutulatus venom: variation in toxicity with geographical origin. Toxicon 16, 81–84.
Gubensek, F., Sket, D., Turk, V., Lebez, D., 1974. Fractionation of Vipera ammodytes venom and seasonal variation of its composition. Toxicon, 12, 167–171.
Guimarães-Gomes, V., Oliveira-Carvalho, A.L., Junqueira-de-Azevedo, I.L., Dutra, D.L.S., Pujol-Luz, M., Castro, H.C., Ho, P.L., Zingali, R.B., 2004. Cloning, characterization and structural analysis of a C-type lectin from Bothrops insularis (BiL) venom. Arch. Biochem. Biophys. 432, 1–11.
Hjort, P.F., 1957. Intermediate reactions in the coagulation of blood with tissue thromboplastin. Scand. J. Clin. Lab. Invest. 9, 1–183.
Hofsteenge, J., Taguchi, H., Stone, S.R., 1986. Effect of thrombomodulin on the kinetics of the interaction of thrombin with substrates and inhibitors. Biochem. J. 237, 243–251.
Hofsteenge, J., Kieffer, B., Matthies, R., Hemmings, B.A., Stone, S.R., 1988. Amino acid sequence of the ribonuclease inhinbitor from porcine liver reveals the presence of leucine-rich repeats. Biochemistry 27, 8537–8544.
Jenny, N.S., Mann, K.G., 1998. Coagulation cascade: an overview, in: Loscalzo, J., Schafer, A.I. (Eds.), Thrombosis and Hemorrhage. Williams and Wilkins, Philadelphia, pp. 3–27.
Jimenez-Porras, J.M., 1964. Intraspecific variations in composition of venom of the jumping viper Bothrops nummifera. Toxicon 2, 187–196.
Kalafatis, M., Rand, M.D., Mann, K.G., 1994. The mechanism of inactivation of human factor V and human factor Va by activated protein C. J. Biol. Chem. 269, 31869–31880.
Kalafatis, M., Egan, J.O., van’t Veer, C., Cawthern, K.M., Mann, K.G., 1997. The regulation of clotting factors. Crit. Rev. Eukaryotic Gene Expression 7, 241–280.
Kamiguti, A.S., 2005. Platelets as targets of snake venom metalloproteinases. Toxicon 45, 1041–1049.
Kawasaki, T., Fujimura, Y., Usami, Y., Suzuki, M., Miura, S., Sakurai, Y., Makita, K., Taniuchi, Y., Hirano, K., Titani, K., 1996. Complete amino acid sequence and identification of the platelet glycoprotein Ib-binding site of jararaca GPIb-BP, a snake venom protein isolated from Bothrops jararaca. J. Biol. Chem. 271, 10635–10639.
Kerns, R.T., Kini, R.M., Stefansson, S., Evans, H.J., 1999. Targeting of venom phospholipases: the strong anticoagulant phospholipase A2 from Naja nigricollis venom binds to coagulation factor Xa to inhibit the prothrombinase complex. Arch. Biochem. Biophys. 369, 107–113.
Kirby, E.P., Niewiarowski, S., Stocker, K., Kettner, C., Shaw, E., Brudzynski, T.M. 1979. Thrombocytin, a serine protease from Bothrops atrox venom. 1. Purification and characterization of the enzyme. Biochemistry 18, 3564–3570.
Koh, Y., Chung, K., Kim, D., 2000. Purification and cDNA cloning of salmorin that inhibits fibrinogen clotting. Thromb. Res. 99, 389–398.
Koo, B.H., Sohn, Y.D., Hwang, K.C., Jang, Y., Kim, D.S., Chung, K.H., 2002. Characterization and cDNA cloning of halyxin, a heterogeneous three-chain anticoagulant protein from the venom of Agkistrodon halys brevicaudus. Toxicon 40, 947–957.
Lee, W.H., Zhang, Y., 2003. Molecular cloning and characterization of a platelet glycoprotein Ib-binding protein from the venom of Trimeresurus stejnegeri. Toxicon 41, 885–892.
Liu, L.W., Vu, T.K.H., Esmon, C.T., Coughlin, S.R., 1991. The region of the thrombin receptor resembling hirudin binds to thrombin and alters enzyme specificity. J. Biol. Chem. 266, 16977–16980.
Magro, A.J., Da Silva, R.J., Ramos, P.R.R., Cherubini, M.R., Hatayde, M.R., 2001. Intraspecific variation in the venom electrophoretic profile of recently captured Crotalus durissus terrificus (Lurenti, 1768) snakes. J. Venom. Anim. Toxins 7, 276–301.
Mann, K.G., 1999. Biochemistry and physiology of blood coagulation. Thromb. Haemost. 82, 165–174.
Mann, K.G., Butenas, S., Brummel, K., 2003. The dynamics of thrombin formation. Arterioscler. Thromb. Vasc. Biol. 23, 17–25.
Maraganore, J.M., Bourdon, P., Jablonski, J., Ramachandran, K.L., Fenton, J.W., 2nd, 1990. Design and characterization of hirulogs: a novel class of bivalent peptide inhibitors of thrombin. Biochemistry 29, 7095–7101.
Markland, F.S., 1998 Snake venoms and the haemostatic system. Toxicon 36, 1749–1800.
Marsh, N., Glatston, A., 1974. Some observations on the venom of the rhinoceros horned viper Bitis nasicornis (Shaw). Toxicon 12, 621–628.
Marsh, N.A., 1994. Snake venoms affecting the haemostatic mechanism – a consideration of their mechanisms, practical applications and biological significance. Blood Coagul. Fibrinol. 5, 399–410.
Matsuda, M., Saeki, E., Kasamatsu, A., Nakamikawa, C., Manabe, S., Samejima, Y., 1985. Fibrinogen Kawaguchi: an abnormal fibrinogencharacterized by defective release of fibrinopeptide A. Thromb. Res. 37, 379–390.
Matsui, T., Fujimura, Y., Titani, K., 2000. Snake venom proteases affecting hemostasis and thrombosis. Biochim. Biophys. Acta 1477, 146–156.
Monteiro, R.Q., Carlini, C.R., Guimarães, J.A., Zingali, R.B., 1997. Distinct bothojaracin isoforms produced by individual jararaca (Bothrops jararaca) snakes. Toxicon 35, 649–657.
Monteiro, R.Q., Dutra, D.L.S., Machado, O.L.T., Carlini, C.R., Guimarães, J.A, Bon, C., Zingali, R.B., 1998. Bothrops jararaca snakes produce several bothrojaracin isoforms following an individual pattern. Comp. Biochem. Physiol. B. 120, 791–798.
Monteiro, R.Q., Raposo, J.G., Wisner,A., Guimarães, J.A., Bon, C., Zingali, R.B., 1999. Allosteric changes of thrombin catalytic site induced by interaction of bothrojaracin with anion-binding exosities I and II. Biochem. Biophys. Res.Comm. 262, 819–822.
Monteiro, R.Q., Zingali, R.B., 2000. Inhibition of prothrombin activation by bothrojaracin, a C-type lectin from Bothrops jararaca venom. Arch. Biochem. Biophys. 382, 123–128.
Monteiro, R.B., Bock, P.E., Bianconi, M.L., Zingali, R.B., 2001. Characterization of bothrojaracin interaction with human prothrombin. Protein Science 10, 1897–1904.
Monteiro, R.Q., Zingali, R.B., 2002. Bothrojaracin, a proexosite I ligand, inhibits factor Va-accelerated prothrombin activation. Thromb. Haemost. 87, 288–293.
Monteiro, R.Q., Foguel, D., Castro, H.C., Zingali, R.B., 2003. Subunit dissociation, unfolding, and inactivation of bothrojaracin, a C-type lectin-like protein from snake venom. Biochemistry 42, 509–515.
Morita, T., 2004. C-type lectin-related proteins from snake venoms. Drug Targets Cardiovasc. Haematol. Disord. 4, 357–373.
Mounier, C.M., Bon, C., Kini, R.M., 2001. Anticoagulant venom and mammalian secreted phospholipase A2: protein versus phospholipid dependent mechanism of action. Haemostasis 31, 279–287.
Myles, T, Yun, T.H., Hall, S.W., Leung, L.L.K., 2001. An extensive interaction interface between thrombin and factor V is required for factor V activation. J. Biol. Chem. 276, 25143–25149.
Murakami, M.T., Arni, R.K., 2005. Thrombomodulin-independent activation of protein C and specificity of hemostatically active snake venom serine proteinases: crystal structures of native and inhibited Agkistrodon contortrix contortrix protein C activator. J. Biol. Chem. 280, 39309–39315.
Nienaber, J., Gaspar, A.R.M., Neitz, A.W., 1999. Savignin, a potent thrombin inhibitor isolated from the salivary glands of the tick Ornithodoros savignyi (Acari: Argasidae). Exp. Parasitol. 20, 583–598.
Oliveira-Carvalho, A.L., Guimarães, P.R., Abreu, P.A., Dutra, D.L., Junqueira-de-Azevedo, I.L., Rodrigues, C.R., Ho, P.L., Castro, H.C., Zingali, R.B., 2008. Identification and characterization of a new member of snake venom thrombin inhibitors from Bothrops insularis using a proteomic approach. Toxicon 51, 659–671.
Peng, M., Lu, W., Kirby, E.P., 1991. Alboaggregin-B: a new platelet agonist that binds to platelet membrane glycoprotein Ib. Biochemistry 30, 11529–11536.
Peng, M., Holt, J.C., Niewiarowski, S., 1994. Isolation, characterization and amino acid sequence of echicetin b subunit, a specific inhibitor of von Willebrand factor and thrombin interaction with glycoprotein Ib. Biochem. Biophys. Res. Commun. 205, 68–72.
Rosing, J., Govers-Riemslag, J.W.P., Yukelson, L., Tans, G., 2001. Factor V activation and inactivation by venom proteases. Hemostasis 31, 241–246.
Salzet, M., Chopin, V., Baerti, J., Matias, I., Malecha, J., 2000. Theromin, a novel leech thrombin inhibitor. J. Biol. Chem. 275, 30774–30780.
Santos, A.B.F., 2000. Interaction of viper venom serine peptidases with thrombin receptors on human platelets. FEBS Lett. 477, 199–202.
Sekiya, F., Atoda, H., Morita, T., 1993. Isolation and characterization of an anticoagulant protein homologous to botrocetin from the venom of Bothrops jararaca. Biochemistry 32, 6892–6897.
Sheehan, J.P., Wu, Q., Tollefsen, D.M., Sadler, J.E., 1993. Mutagenesis selectively modulates inhibition by serpins heparin cofactor II and antithrombin III. Interaction with the anion-binding exosite determines heparin cofactor II specificity. J. Biol. Chem. 268, 3639–3645.
Shiau, S.Y., Ouyang, C., 1965. Isolation of coagulant and anticoagulant principles from the venom of Trimeresurus gramineus. Toxicon 69, 213–220.
Solorzano, A., Romero, M., Gutiérrez, J.M., Sasa, M., 1999. Venom composition and diet of the cantil Agkistrodon bilineatus howardgloydi (Serpentes: Viperidae). Southwest. Nat. 44, 478–483.
Stefano, G.B., Scharrer, B., Smith, E.M., Hughes, T.K., Magazine, H.I., Bilfinger, T.V., Hartman, A.R., Fricchione, G.L., Liu, Y., Makman, M.H., 1996. Opioid and opiate immunoregulatory processes. Crit. Rev. Immunol. 16, 109–144.
Stone, S.R., Hofsteenge, J., 1986. Kinetics of the inhibition of thrombin by hirudin. Biochemistry 25, 4622–4628.
Stone, S.R., Brown-Luedi, M.L., Rovelli, G., Guidolin, A., McGlynn, E., Monard, D., 1994. Localization of the heparin-binding site of glia-derived nexin/protease nexin 1 by site-directed mutagenesis. Biochemistry 33, 7731–7735.
Strube, K.H., Kroger, B., Biolojan, S., Otte, M., Dodt, J., 1993. Isolation, sequence analysis, and cloning of haemadin. An anticoagulant peptide from the Indian leech. J. Biol. Chem. 268, 8590–8595.
Tani, A., Ogawa, T., Nose, T., Nikandrov, N.N., Deshimaru, M., Chijiwa, T., Chang, C.C., Fukumaki, Y., Ohno, M., 2002. Characterization, primary structure and molecular evolution of anticoagulant protein from Agkistrodon acutus venom. Toxicon 40, 803–813.
Taniuchi, Y., Kawasaki, T., Fujimura, Y., Suzuki, M., Titani, K., Sakai, Y., Kaku, S., Hisamichi, N., Satoh, N., Takenaka, T., Handa, M., Sawai, Y., 1995. Flavocetin-A and -B, two high molecular mass glycoprotein Ib binding proteins with high affinity purified from Trimeresurus flavoviridis venom, inhibit platelet aggregation at high shear stress. Biochim. Biophys. Acta 1244, 331–338.
Usami, Y., Fujimura, Y., Suzuki, M., Ozeki, Y., Nishio, K., Fukui, H., Titani, K., 1993. Primary structure of two-chain botrocetin, a von Willebrand factor modulator purified from the venom of Bothrops jararaca. Proc. Natl. Acad. Sci. U.S.A. 90, 928–932.
Van de Locht, A, Stubbs, M., Bode, W., Friedrich, T., Bol-Ilschweiler, C., Höffken, W, Huber, R., 1996. The ornithodorin-thrombin crystal structure, a key to the TAP enigma? EMBO J. 15, 6011–6017.
Verstraete, M., Zoldhelyi, P., 1995. Novel antithrombotic drugs in development. Drugs 49, 856–884.
Xu, Q., Wu, X.F., Xia, Q.C., Wang, K.Y., 1999. Cloning of a galactose-binding lectin from the venom of Trimeresurus stejnegeri. Biochem. J. 341, 733–737.
Xu, X., Liu, Q., Xie, Y., Wu, S.D., 2000. Purification and characterization of anticoagulation factors from the venom of Agkistrodon acutus. Toxicon 38, 1517–1528.
Weinger, R.S., Rudy, C., Moake, J.L., Olson, J.D., Cimo, P.L., 1980. Prothrombin Houston: a dysprothrombin identifiable by crossed immunoelectrofocusing and abnormal Echis carinatus venom activation. Blood 55, 811–816.
Wang, W.J., Huang, T.F., 2001. A novel tetrameric venom protein, agglucetin, from Agkistrodon acutus, acts as a glycoprotein Ib agonist. Thromb. Haemost. 86, 1077–1086.
Yeh, C.H., Peng, H.C., Yang, R.S., Huang, T.F., 2001. Rhodostomin, a snake venom disintegrin, inhibits angiogenesis elicited by basic fibroblast growth factor and suppresses tumor growth by a selective αvβ3 blockade of endothelial cells. Mol. Pharmacol. 59, 1333–1342.
Zang, J., Teng, M., Niu, L., 2003. Purification, crystallization and preliminary crystallographic analysis of AHP IX-bp, a zinc ion and pH-dependent coagulation factor IX binding protein from Agkistrodon halys pallas venom. Acta Crystallogr. D. Biol. Crystallogr. 59, 730–733.
Zhang, Y., Wisner, A., Maroun, R.C., Choumet, V., Xiong, Y., Bon, C., 1997. Trimeresurus stejnegeri snake venom plasminogen activator. Site directed mutagenesis and molecular modeling. J. Biol. Chem. 272, 20531–20537.
Zingali, R.B., Jandrot-Perrus, M., Guillin, M.C., Bon, C., 1993. Bothrojaracin, a new thrombin inhibitor isolated from Bothrops jararaca venom: characterization and mechanism of thrombin inhibition. Biochemistry 32, 10794–10802.
Zingali, R.B., Bianconi, M.L., Monteiro, R.Q., 2001. Interaction of bothrojaracin with prothrombin. Haemostasis 31, 273–278.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Zingali, R.B., Nogueira, A.C.F. (2010). Bothrojaracin – A Potent Thrombin Inhibitor. In: Kini, R., Clemetson, K., Markland, F., McLane, M., Morita, T. (eds) Toxins and Hemostasis. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-9295-3_12
Download citation
DOI: https://doi.org/10.1007/978-90-481-9295-3_12
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-9294-6
Online ISBN: 978-90-481-9295-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)